A multicenter, prospective validation study of the Japanese Association for Acute Medicine disseminated intravascular coagulation scoring system in patients with severe sepsis

IntroductionTo validate the Japanese Association for Acute Medicine (JAAM) disseminated intravascular coagulation (DIC) scoring system in patients with severe sepsis, we conducted a multicenter, prospective study at 15 critical care centers in tertiary care hospitals.MethodsThis study included 624 severe sepsis patients. JAAM DIC was scored on the day of diagnosis of severe sepsis (day 1) and day 4. Scores for disease severity and organ dysfunction were also evaluated.ResultsThe prevalence of JAAM DIC was 46.8% (292/624), and 21% of the DIC patients were scored according to the reduction rate of platelets. The JAAM DIC patients were more seriously ill and exhibited more severe systemic inflammation, a higher prevalence of multiple organ dysfunction syndrome (MODS) and worse outcomes than the non-DIC patients. Disease severity, systemic inflammation, MODS and the mortality rate worsened in accordance with an increased JAAM DIC score on day 1. The Kaplan-Meier curves demonstrated lower 1-year survival in the JAAM DIC patients than in those without DIC (log-rank test P <0.001). The JAAM DIC score on day 1 (odds ratio = 1.282, P <0.001) and the Delta JAAM DIC score (odds ratio = 0.770, P <0.001) were independent predictors of 28-day death. Dynamic changes in the JAAM DIC score from days 1 to 4 also affected prognoses. The JAAM DIC scoring system included all patients who met the International Society on Thrombosis and Haemostasis overt DIC criteria on day 1. The International Society on Thrombosis and Haemostasis scoring system missed a large number of nonsurvivors recognized by the JAAM scoring system.ConclusionsThe JAAM DIC scoring system exhibits good prognostic value in predicting MODS and poor prognosis in patients with severe sepsis and can detect more patients requiring treatment. Conducting repeated daily JAAM scoring increases the ability to predict the patient's prognosis.

[1]  T Maekawa,et al.  Criteria for diagnosis of DIC based on the analysis of clinical and laboratory findings in 345 DIC patients collected by the Research Committee on DIC in Japan. , 1983, Bibliotheca haematologica.

[2]  W. Knaus,et al.  APACHE II: a severity of disease classification system. , 1985 .

[3]  J. E. Carceller.  American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis , 1992, Critical care medicine.

[4]  W. Knaus,et al.  Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. , 1992, Chest.

[5]  D. Pittet,et al.  The natural history of the systemic inflammatory response syndrome (SIRS). A prospective study. , 1995, JAMA.

[6]  H. Shiku,et al.  Outcome of Disseminated Intravascular Coagulation in Relation to the Score when Treatment was Begun , 1995, Thrombosis and Haemostasis.

[7]  S. Gando,et al.  Disseminated Intravascular Coagulation Is a Frequent Complication of Systemic Inflammatory Response Syndrome , 1996, Thrombosis and Haemostasis.

[8]  F B Taylor,et al.  Towards Definition, Clinical and Laboratory Criteria, and a Scoring System for Disseminated Intravascular Coagulation , 2001, Thrombosis and Haemostasis.

[9]  J. Vincent,et al.  Serial evaluation of the SOFA score to predict outcome in critically ill patients. , 2001, JAMA.

[10]  Mitchell M. Levy,et al.  2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference , 2003, Intensive Care Medicine.

[11]  Saxon Ridley.  Critical care. , 2003, Anaesthesia.

[12]  M. Levy,et al.  2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference , 2003, Intensive care medicine.

[13]  V. Pettilä,et al.  Treatment effects of drotrecogin alfa (activated) in patients with severe sepsis with or without overt disseminated intravascular coagulation 1 , 2004, Journal of thrombosis and haemostasis : JTH.

[14]  E. de Jonge,et al.  Prospective validation of the International Society of Thrombosis and Haemostasis scoring system for disseminated intravascular coagulation* , 2004, Critical care medicine.

[15]  T. van der Poll,et al.  Sepsis and Disseminated Intravascular Coagulation , 2003, Journal of Thrombosis and Thrombolysis.

[16]  K. Reinhart,et al.  Dynamic evolution of coagulopathy in the first day of severe sepsis: Relationship with mortality and organ failure* , 2005, Critical care medicine.

[17]  C. Toh,et al.  Performance and prognostic importance of a new clinical and laboratory scoring system for identifying non-overt disseminated intravascular coagulation , 2005, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

[18]  S. Opal,et al.  Treatment effects of high‐dose antithrombin without concomitant heparin in patients with severe sepsis with or without disseminated intravascular coagulation , 2006, Journal of thrombosis and haemostasis : JTH.

[19]  Yasuhiro Ohtomo,et al.  A multicenter, prospective validation of disseminated intravascular coagulation diagnostic criteria for critically ill patients: Comparing current criteria* , 2006, Critical care medicine.

[20]  S. Kushimoto,et al.  Natural history of disseminated intravascular coagulation diagnosed based on the newly established diagnostic criteria for critically ill patients: Results of a multicenter, prospective survey* , 2008, Critical care medicine.

[21]  J. Thachil,et al.  Guidelines for the diagnosis and management of disseminated intravascular coagulation , 2009, British journal of haematology.

[22]  S. Kushimoto,et al.  Disseminated intravascular coagulation (DIC) diagnosed based on the Japanese Association for Acute Medicine criteria is a dependent continuum to overt DIC in patients with sepsis. , 2009, Thrombosis research.

[23]  S. Madoiwa,et al.  Expert consensus for the treatment of disseminated intravascular coagulation in Japan. , 2010, Thrombosis research.

[24]  M. Ashraf.  Prognostic value of a simple evolving disseminated intravascular coagulation score in patients with severe sepsis , 2010 .

[25]  Satoshi Gando,et al.  Microvascular thrombosis and multiple organ dysfunction syndrome , 2010, Critical care medicine.

[26]  I. Maruyama,et al.  THROMBOMODULIN ALFA IN THE TREATMENT OF INFECTIOUS PATIENTS COMPLICATED BY DISSEMINATED INTRAVASCULAR COAGULATION: SUBANALYSIS FROM THE PHASE 3 TRIAL , 2011, Shock.

[27]  M. Di Nisio,et al.  Diagnosis and treatment of disseminated intravascular coagulation: guidelines of the Italian Society for Haemostasis and Thrombosis (SISET). , 2012, Thrombosis Research.

[28]  S. Gando.  The utility of a diagnostic scoring system for disseminated intravascular coagulation. , 2012, Critical care clinics.

[29]  Ratender K. Singh,et al.  Prospective comparison of new Japanese Association for Acute Medicine (JAAM) DIC and International Society of Thrombosis and Hemostasis (ISTH) DIC score in critically ill septic patients. , 2012, Thrombosis research.

[30]  N. Takeyama,et al.  Epidemiology of severe sepsis in Japanese intensive care units: a prospective multicenter study. , 2014, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy.